Mary Wilson
Well-known member
30 MAY 2023 11:30 AM
By JON COHEN
The U.S. government has tens of millions of unused doses of messenger RNA (mRNA) COVID-19 vaccines, regularly trashing shots as they pass their expiration dates. It’s a dismal reflection on recent vaccine uptake, but it’s also a serious roadblock for scientists testing and developing vaccines that could protect against future variants of SARS-CoV-2—and the next pandemic. Developers need existing vaccines as a benchmark to compare with new candidates. But government contracts with the vaccinemakers, and the companies’ own policies, prohibit the use of the vaccines for research purposes.
“At this stage of the game, with millions of vaccines on the verge of being thrown away, this seems crazy,” says Nicole Lurie, U.S. director of the Coalition for Epidemic Preparedness Innovations (CEPI). The situation is so dire that one startup has created mimics of the mRNA vaccines in use to help researchers improve their formulations.
Most researchers working on next-generation vaccines hope to create products that stimulate broader immunity to protect people from all sarbecoviruses, a group that includes variants of SARS-CoV-2, SARS-CoV-1, and related viruses found in bats and other wild animals that might spill over to humans. As part of the development process, researchers want to compare their candidates in animal models to the proven Moderna and Pfizer mRNA vaccines. ...
https://www.science.org/content/art...vid-19-shots-stalling-future-vaccine-research
By JON COHEN
The U.S. government has tens of millions of unused doses of messenger RNA (mRNA) COVID-19 vaccines, regularly trashing shots as they pass their expiration dates. It’s a dismal reflection on recent vaccine uptake, but it’s also a serious roadblock for scientists testing and developing vaccines that could protect against future variants of SARS-CoV-2—and the next pandemic. Developers need existing vaccines as a benchmark to compare with new candidates. But government contracts with the vaccinemakers, and the companies’ own policies, prohibit the use of the vaccines for research purposes.
“At this stage of the game, with millions of vaccines on the verge of being thrown away, this seems crazy,” says Nicole Lurie, U.S. director of the Coalition for Epidemic Preparedness Innovations (CEPI). The situation is so dire that one startup has created mimics of the mRNA vaccines in use to help researchers improve their formulations.
Most researchers working on next-generation vaccines hope to create products that stimulate broader immunity to protect people from all sarbecoviruses, a group that includes variants of SARS-CoV-2, SARS-CoV-1, and related viruses found in bats and other wild animals that might spill over to humans. As part of the development process, researchers want to compare their candidates in animal models to the proven Moderna and Pfizer mRNA vaccines. ...
https://www.science.org/content/art...vid-19-shots-stalling-future-vaccine-research